sequenom inc (SQNM:NASDAQ GS)
Paul V. Maier M.B.A.
Chief Financial Officer, Sequenom Inc.
|Age||Total Calculated Compensation||This person is connected to 41 board members in 4 different organizations across 8 different industries.|
See Board Relationships
As of Fiscal Year 2012
Mr. Paul V. Maier, M.B.A. has been the Chief Financial Officer at Sequenom Inc. since June 2010. Mr. Maier has been an Independent Financial Consultant since February 2007. He has over 20 years of experience as a senior executive in biotechnology and pharmaceutical companies. He served as Chief Financial Officer and Senior Vice President at Organon Pharmaceuticals USA, Inc. He served as a Consultant from October 2009 to November 10, 2009 and Interim Chief Financial Officer ...
Corporate Headquarters*3595 John Hopkins Court
San Diego, California 92121
Board Members Memberships*
Former Director, Chairman of Audit Committee and Member of Nominating and Corporate Governance Committee
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Governance Committee
Director, Chairman of Audit Committee and Chairman of Compensation Committee
Director, Chairman of Audit Committee, Member of Special Committee and Member of Finance & Transactions Committee
Director, Member of Audit Committee and Member of Corporate Governance/Nominating Committee
Pennsylvania State University
|Barry G. Caldwell||Chief Executive Officer, President and Director|
STAAR Surgical Company
|Joseph P. Caruso||Chairman, Chief Executive Officer and President|
Palomar Medical Technologies Inc.
|Gary R. Maharaj||Chief Executive Officer, President and Director|
|Gajus V. Worthington||Co-Founder, Chief Executive Officer, President and Director|
|Paul K. Wotton Ph.D.||Chief Executive Officer, President and Director|
Antares Pharma Inc.
|$477.0K||Compensation as of Fiscal Year 2012.|